Presence of Apo B48, and relative Apo CII deficiency and Apo CIII enrichment in uremic very-low density lipoproteins
- PMID: 2690681
Presence of Apo B48, and relative Apo CII deficiency and Apo CIII enrichment in uremic very-low density lipoproteins
Abstract
In the present study, lipid and apolipoprotein composition of very low density lipoprotein (VLDL) was analyzed in 39 patients with end-stage renal failure by comparison with 41 healthy subjects. Uremic patients had an increase of serum triglycerides (TG) concentration by comparison with control values. This increase of serum TG was associated with an increase of VLDL which had a normal percent amount of main components. Furthermore a mid-band between VLDL and low density lipoproteins (LDL) on polyacrylamide gel was observed in 22 out of 39 uremic patients but in only 1 out of 41 control subjects. In uremic VLDL Apo B48 was more frequently observed than in control VLDL (p less than 0.05). Furthermore, the content of Apo CII expressed as percent of total Apo C was significantly (p less than 0.001) decreased in uremic VLDL (19.13 +/- 4.54 p. cent) as compared to normal VLDL (23.57 +/- 4.40 p. cent). Apo CIII-O was significantly (p less than 0.001) increased (9.58 +/- 7.19 p. cent vs 5.55 +/- 6.12 p. cent, whereas Apo CIII-1 and Apo CIII-2 distribution was not modified in uremic VLDL. These anomalies were present in uremic patients even when no elevation of fasting serum TG was present. No significant change was observed in uremic patients before their fifth as compared to their first hemodialysis (HD) session, respectively, for any of the parameters studied. Advanced chronic renal failure is associated with a variety of anomalies of TG-rich lipoproteins isolated at d less than 1.006 g/ml which are not reflected by the degree of hypertriglyceridemia and are not corrected by the first four HD sessions.
Similar articles
-
Anomalies in composition of uremic lipoproteins isolated by gradient ultracentrifugation: relative enrichment of HDL in apolipoprotein C-III at the expense of apolipoprotein A-I.Atherosclerosis. 1988 Nov;74(1-2):75-83. doi: 10.1016/0021-9150(88)90193-1. Atherosclerosis. 1988. PMID: 3145749
-
Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.Kidney Int. 1999 Apr;55(4):1536-42. doi: 10.1046/j.1523-1755.1999.00375.x. Kidney Int. 1999. PMID: 10201020
-
Decreased VLDL apoprotein CII/apoprotein CIII ratio may be seen in both normotriglyceridemic and hypertriglyceridemic patients on chronic hemodialysis treatment.Metabolism. 1987 Sep;36(9):815-20. doi: 10.1016/0026-0495(87)90087-4. Metabolism. 1987. PMID: 3626863
-
[Anomalies of lipoprotein metabolism in chronic renal insufficiency].Nephrologie. 1993;14(2):75-90. Nephrologie. 1993. PMID: 8327031 Review. French.
-
Is there a treatment necessity for lipid disorders of uremic patients?Blood Purif. 1985;3(1-3):42-51. doi: 10.1159/000169397. Blood Purif. 1985. PMID: 3938287 Review.
Cited by
-
Fasting, non-fasting and postprandial triglycerides for screening cardiometabolic risk.J Nutr Sci. 2021 Sep 14;10:e75. doi: 10.1017/jns.2021.73. eCollection 2021. J Nutr Sci. 2021. PMID: 34589207 Free PMC article. Review.
-
Reduced apolipoprotein glycosylation in patients with the metabolic syndrome.PLoS One. 2014 Aug 12;9(8):e104833. doi: 10.1371/journal.pone.0104833. eCollection 2014. PLoS One. 2014. PMID: 25118169 Free PMC article.
-
Very Low Density Lipoprotein Metabolism in Patients with Chronic Kidney Disease.Cardiorenal Med. 2012 Feb;2(1):57-65. doi: 10.1159/000335509. Epub 2012 Jan 26. Cardiorenal Med. 2012. PMID: 22493604 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous